Evolus (EOLS) news
Recent news
Evolus pays $1.5M option for injectable restoration program
AInvest Wire · 1d agoEvolus gets option to buy 100% of Hair Restoration assets
Evolus, Inc. (NASDAQ: EOLS) has announced it has secured the option to acquire 100% of the Hair Restoration assets from an unnamed third party, marking a strategic expansion into a new segment of the aesthetics market. The move aligns with the company’s broader objective of becoming a multi-product…
AInvest Wire · 1d agoQatar fuel - Overall sales volume recorded a 14% decrease in 9-months
Qatar Fuel (QSE: QFLS) reported a 14% decline in overall sales volume over the first nine months of 2026, according to recent data. This marks a notable shift from previous performance, as the company had experienced robust growth in recent years. For instance, in FY 2025, the company recorded…
AInvest Wire · 1d agoEvolus shares drop as much as 10% after FDA letter
Evolus Inc. (NASDAQ: EOLS) shares fell as much as 10% in early trading on October 2, 2026, following the release of a letter from the U.S. Food and Drug Administration (FDA) regarding the company’s product pipeline. While the letter did not specify the exact nature of the FDA’s concerns, it is…
AInvest Wire · Oct 2, 2026FDA asks Evolus to take immediate action to address violations
AInvest Wire · Oct 2, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.